During the past decade, Emmed Research conducted 26 clinical trials. In the 10-year time frame, 26 clinical trials started and 17 clinical trials were completed, i.e. on average, 65.4% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 12 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Emmed Research" #1 sponsor was "Pfizer" with 8 trials, followed by "Hoffmann-La Roche" with 7 trials sponsored, "Celgene" with 5 trials sponsored, "Janssen Research & Development, LLC" with 4 trials sponsored and "BioCryst Pharmaceuticals" with 4 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Emmed Research" #1 collaborator was "Brigham and Women's Hospital" with 1 trials as a collaborator, "Daiichi Sankyo Co., Ltd." with 1 trials as a collaborator, "Department of Health and Human Services" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator and "Merck KGaA, Darmstadt, Germany" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Emmed Research" are "Crohn Disease" (5 trials), "Rheumatoid Arthritis" (5 trials), "Influenza" (3 trials), "Ulcerative Colitis" (3 trials) and "Colitis, Ulcerative" (2 trials). Many other conditions were trialed in "Emmed Research" in a lesser frequency.

Most popular intervention types in "Emmed Research" are "Drug" (29 trials), "Other" (8 trials) and "Biological" (5 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (19 trials), "Etrolizumab" (4 trials), "Ozanimod" (3 trials), "Pimodivir 600 mg" (2 trials) and "RPC1063" (2 trials). Other intervention names were less common.

The vast majority of trials in "Emmed Research" are 32 trials for "All" genders.

Currently, there are NaN active trials in "Emmed Research". undefined are not yet recruiting, 8 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 16 completed trials in Emmed Research, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Emmed Research, 0 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 22 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".